Christopher Lindop
2008 - Haemonetics
In 2008, Christopher Lindop earned a total compensation of $915.2K as Chief Financial Officer Vice President of Business Development at Haemonetics, a 113% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $99,549 |
|---|---|
| Option Awards | $362,454 |
| Salary | $385,000 |
| Stock Awards | $68,102 |
| Other | $102 |
| Total | $915,207 |
Lindop received $385K in salary, accounting for 42% of the total pay in 2008.
Lindop also received $99.5K in non-equity incentive plan, $362.5K in option awards, $68.1K in stock awards and $102 in other compensation.
Rankings
In 2008, Christopher Lindop's compensation ranked 4,665th out of 9,135 executives tracked by ExecPay. In other words, Lindop earned more than 48.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,665 out of 9,135 | 49th |
Division Manufacturing | 1,677 out of 3,436 | 51st |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 238 out of 517 | 54th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 117 out of 272 | 57th |
Industry Surgical and Medical Instruments and Apparatus | 75 out of 179 | 58th |
Source: SEC filing on June 17, 2010.
Lindop's colleagues
We found four more compensation records of executives who worked with Christopher Lindop at Haemonetics in 2008.